T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPI
2151
DELISTED
Office Properties Income Trust
OPI
| $807K | ﹤0.01% |
27,543
+923
| +3% | +$26.5K |
|
|
LMNX
2152
DELISTED
Luminex Corp
LMNX
| $807K | ﹤0.01% |
21,937
-3,561
| -14% | -$129K |
|
2153
Genesco
GCO
$394M
| $805K | ﹤0.01% |
12,635
-4,138
| -25% | -$224K |
|
2154
Blink Charging
BLNK
$87.1M
| $802K | ﹤0.01% |
19,490
+2,190
| +13% | +$81.2K |
|
2155
Tennant Co
TNC
$1.15B
| $802K | ﹤0.01% |
10,040
+342
| +4% | +$28K |
|
2156
Goosehead Insurance
GSHD
$2.39B
| $799K | ﹤0.01% |
6,273
+583
| +10% | +$59.4K |
|
|
VIVO
2157
DELISTED
Meridian Bioscience Inc
VIVO
| $796K | ﹤0.01% |
35,908
+793
| +2% | +$16.8K |
|
2158
Tactile Systems Technology
TCMD
$537M
| $795K | ﹤0.01% |
15,295
+322
| +2% | +$17.4K |
|
2159
Unitil
UTL
$992M
| $793K | ﹤0.01% |
14,968
-2,741
| -15% | -$147K |
|
2160
Workhorse Group
WKHS
$33.1M
| $793K | ﹤0.01% |
16
+4
| +33% | +$148K |
|
2161
PUT
Alcoa
AA
$13.1B
| $792K | ﹤0.01% |
+21,500
| New | +$782K |
|
2162
Modine Manufacturing
MOD
$10.8B
| $792K | ﹤0.01% |
47,769
-11,579
| -20% | -$190K |
|
|
AMWD
2163
DELISTED
American Woodmark
AMWD
| $785K | ﹤0.01% |
9,605
+29
| +0.3% | +$2.71K |
|
2164
Heron Therapeutics
HRTX
$63.5M
| $785K | ﹤0.01% |
50,595
-6,826
| -12% | -$109K |
|
2165
Varex Imaging
VREX
$780M
| $785K | ﹤0.01% |
29,278
+4,406
| +18% | +$108K |
|
|
FFWM
2166
DELISTED
First Foundation Inc
FFWM
| $784K | ﹤0.01% |
34,841
+4,999
| +17% | +$120K |
|
|
GTY
2167
Getty Realty Corp
GTY
$2.05B
| $782K | ﹤0.01% |
25,090
+8,467
| +51% | +$265K |
|
|
GPMT
2168
Granite Point Mortgage Trust
GPMT
$58.8M
| $776K | ﹤0.01% |
52,636
-6,857
| -12% | -$94.6K |
|
|
SHYF
2169
DELISTED
The Shyft Group
SHYF
| $774K | ﹤0.01% |
20,684
-5,881
| -22% | -$222K |
|
2170
Evolent Health
EVH
$527M
| $772K | ﹤0.01% |
36,572
-661
| -2% | -$13.2K |
|
2171
Hamilton Lane
HLNE
$5.91B
| $771K | ﹤0.01% |
8,458
+1,092
| +15% | +$98.9K |
|
|
NXGN
2172
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $768K | ﹤0.01% |
46,305
-10,690
| -19% | -$192K |
|
2173
Pitney Bowes
PBI
$2.28B
| $765K | ﹤0.01% |
87,198
-415
| -0.5% | -$3.46K |
|
2174
Southside Bancshares
SBSI
$984M
| $761K | ﹤0.01% |
19,900
-7,441
| -27% | -$304K |
|
2175
NETSCOUT
NTCT
$2.89B
| $760K | ﹤0.01% |
26,619
-8,079
| -23% | -$230K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.